Академический Документы
Профессиональный Документы
Культура Документы
Steven Z. Pantilat, MD
Education Guides Editor
Ms Hs Story
Ms Hs Story
Ms Hs Story
Ms Hs Story
Ms Hs Story
Ms Hs Story
Ms Hs Story
Ms Hs Story
Epidemiology
Pathophysiology
Assessment of Patients
Assessment of Patients
Symptoms include
Diminished sensation over buttocks, posteriorsuperior thighs, and perineal region
Decreased anal sphincter tone in 20%-80% of cases
Radiculopathy
Weakness
Sensory changes
Sphincter incontinence
Autonomic dysfunction (urinary hesitancy,
retention)
Assessment of Patients
MRI of the entire spine should include T1weighted sagittal images with T1- or T2weighted axial images in areas of interest
Patients with prostate cancer with more than
20 bone metastases and who have taken
hormone therapy have a 44% incidence of
spinal epidural disease
MRI of the spine might be considered even before
development of symptoms of spinal cord
compression
Goals of Treatment
Glucocorticoid Therapy
Glucocorticoid Therapy
Glucocorticoid Therapy
Guideline recommendations
High dose dexamethasone was a Grade A
recommendation
Optimal dose not known
Dexamethasone 6-10 mg oral or intravenous bolus
with taper during or immediately after radiation
therapy
Complications
Anxiety, insomnia, delirium
Oral candidiasis: consider fluconazole 100 mg orally
daily
Glucose intolerance
Pneumocystis jiroveci: if a prolonged course of
dexamethasone is planned, consider prophylaxis
with trimethoprim and sulfamethoxazole
Stereotactic radiosurgery
Patients receive 1 large dose (eg, 6-8 Gy) to a
localized tumor with a precisely shaped radiation
beam
Patients must be able to physically and emotionally
tolerate staying still for the 90 minutes of treatment
Few studies compare stereotactic radiosurgery to
standard radiation therapy
One retrospective study found similar ambulation,
performance status, and pain control for patients treated
for recurrent disease
Surgery
Surgery
Ms H has a score of 15
General condition: 2
Extraspinal metastases: 2
Vertebral body metastases: 2
Metastases to major internal organs: 2
Primary site of cancer: 5
Palsy or myelopathy: 2
Surgery
Surgical Complications
Prognosis
Normal
Bladder
Function
Fully ambulatory
64%
27%
9%
69%
Needing assistance
37%
31%
48%
36%
15%
33%
61%
33%
Prognosis
Prognosis
Median
Survival
1-Year
Survival
Myeloma
6.4 months
39%
Lymphoma
6.7 months
38%
4 months
27%
1.5 months
22%
Prostate cancer
Lung cancer
Median and 1-year survival with spinal cord compression is poor and
varies by type of cancer. Median survival is 9 months for patients
ambulatory after treatment vs 1-2 months for patients nonambulatory
after treatment.
Care at the Close of Life: Evidence and Experience
Copyright American Medical Association. All rights reserved. | JAMA | The McGraw-Hill Companies, Inc.
Prognosis
Rehabilitation
Associated with
Increased satisfaction with life
Less depression
Persistent decreases in pain
Inpatient Rehabilitation
Palliative Care
Palliative Care
Palliative Care
Palliative Care
Palliative Care
Palliative Care
Conclusion
Conclusion
Janet L. Abrahm, MD
Harvard Medical School
Steven Z. Pantilat, MD
Education Guides Editor
Stephen J. McPhee, MD; Margaret A. Winker, MD; Michael W. Rabow, MD; Steven Z. Pantilat, MD; Amy J. Markowitz, JD
Care at the Close of Life: Evidence and Experience Editors
Care at the Close of Life: Evidence and Experience
Copyright American Medical Association. All rights reserved. | JAMA | The McGraw-Hill Companies, Inc.
Terms of Use
Care at the Close of Life Education Guides
PowerPoint Usage Guidelines
JAMAevidence users may display, download, or print out
PowerPoint slides and images associated with the site for
personal and educational use only. Educational use refers to
classroom teaching, lectures, presentations, rounds, and
other instructional activities, such as displaying, linking to,
downloading, printing and making and distributing multiple
copies of said isolated materials in both print and electronic
format. Users will only display, distribute, or otherwise make
such PowerPoint slides and images from the applicable
JAMAevidence materials available to students or other
persons attending in-person presentations, lectures, rounds
or other similar instructional activities presented or given by
User.
Commercial use of the PowerPoint slides and images are
not permitted under this agreement. Users may modify the
content of
downloaded PowerPoint slides only for
Care at the Close of Life: Evidence and Experience
Copyright American Medical Association. All rights reserved. | JAMA | The McGraw-Hill Companies, Inc.
educational
(non-commercial) use, however the source and